UNSPSC 51101659: Fexinidazole

This classification denotes an antiprotozoal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 306ERL82IR. European Medicines Agency schedules Fexinidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07618MIG. Fexinidazole generally arises in the molecular formula C12H13N3O3S.

UNSPSC 51101659 Fexinidazole is a Commodity code nominally identifying a specific antiparasitic pharmaceutical agent, but recent state and local solicitations tagged under this code do not consistently purchase fexinidazole itself. Instead, the code appears in procurement activity spanning naloxone distribution systems, therapeutic pharmacy initiative program design, emergency medical and first aid supplies for fire rescue operations, and generic multi-source pharmaceutical and over-the-counter product procurement through cooperative purchasing vehicles. The issuing bodies include county health departments, state health and human services agencies, municipal fire departments, and state procurement offices administering multistate cooperative agreements. Work ranges from tactical procurement of specific finished goods—such as naloxone units and drug deactivation systems for community health use, or medical consumables for emergency response—to strategic contracting for pharmaceutical manufacturing capacity and wholesale distribution relationships serving multiple state and local entities.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued an IFB on June 30, 2026 (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building, estimated at $700,000 under a two-year initial term plus one-year renewal option. The Texas Health and Human Services Commission posted an RFI on April 3, 2026 to solicit vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information about direct contracting relationships between the state pharmacy benefit program and manufacturers outside traditional pharmacy benefit manager and group purchasing organization channels. The City of Tampa issued an IFB on March 25, 2026 (due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, designated as a sheltered market procurement for certified Small Local Business Enterprises with a 5 percent bid discount not to exceed $10,000. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers—AmerisourceBergen (Cencora), Cardinal Health, and Morris & Dickson—with products effective July 1, 2026 and evaluation weighted 75 percent on price competitiveness.